A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
Public ClinicalTrials.gov record NCT02950064. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Escalation Study of BTP-114 in Patients With Advanced Solid Tumors and BRCA or DNA Repair Mutation
Study identification
- NCT ID
- NCT02950064
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Placon Therapeutics
- Industry
- Enrollment
- 95 participants
Conditions and interventions
Interventions
- BTP-114 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2016
- Primary completion
- Mar 31, 2020
- Completion
- Jul 31, 2020
- Last update posted
- Jan 13, 2019
2016 – 2020
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Placon Therapeutics Clinical Trial Site | Sarasota | Florida | 34232 | — |
| Placon Therapeutics Clinical Trial Site | Boston | Massachusetts | 02114 | — |
| Placon Therapeutics Clinical Trial Site | Boston | Massachusetts | 02215 | — |
| Placon Therapeutics Clinical Trial Site | St Louis | Missouri | 63110 | — |
| Placon Therapeutics Clinical Trial Site | Cleveland | Ohio | 44106 | — |
| Placon Therapeutics Clinical Trial Site | Oklahoma City | Oklahoma | 73104 | — |
| Placon Therapeutics Clinical Trial Site | Nashville | Tennessee | 37203 | — |
| Placon Therapeutics Clinical Trial Site | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02950064, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2019 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02950064 live on ClinicalTrials.gov.